Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Methotrexate side effects vary by race and sex.

The document encourages attending the 2023 Dermatology Nurses' Association Convention.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Certain hairstyles and less hair oil use in African American girls can lead to scalp conditions like traction alopecia and seborrheic dermatitis.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Genetic variants at 20p11 increase baldness risk in Chinese Han people.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

19.7% of Afro-Caribbean women in Tobago have PCOS.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Probiotic bacteria improved skin and hair health in aged mice.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.